Directors’ Deals: AstraZeneca chair bets on upward momentum by | May 12, 2023 | News | 0 comments Pharma group’s shares are up more than 120 per cent in the past five years Submit a Comment Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.